Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors and cellular treatment for lymphoma immunotherapy.
Li, F; Chen, Y; Pang, M; Yang, P; Jing, H.
Affiliation
  • Li F; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Chen Y; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Pang M; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Yang P; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Jing H; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
Clin Exp Immunol ; 205(1): 1-11, 2021 07.
Article in En | MEDLINE | ID: mdl-33675535
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Lymphoma Limits: Animals / Humans Language: En Journal: Clin Exp Immunol Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Lymphoma Limits: Animals / Humans Language: En Journal: Clin Exp Immunol Year: 2021 Document type: Article